Archive | December, 2009
Nzu, Traditional Remedy for Morning Sickness
Consumers, especially pregnant or breastfeeding women, advised to avoid product because of the potential health risks from high levels of lead and arsenic
Continue reading...Nzu, Traditional Remedy for Morning Sickness
31. December 2009
Comments Off
Consumers, especially pregnant or breastfeeding women, advised to avoid product because of the potential health risks from high levels of lead and arsenic
Continue reading...Thermoflect Blankets and product line – Recall
28. December 2009
Comments Off
FDA recommends blankets and other products not be used in magnetic resonance [MR] conditional or MR compatible environments
Continue reading...Thermoflect Blankets and product line – Recall
28. December 2009
Comments Off
FDA recommends blankets and other products not be used in magnetic resonance [MR] conditional or MR compatible environments
Continue reading...Cordis CROSSOVER Sheath Introducer – Recall
23. December 2009
Comments Off
[UPDATED 12/23/2009] Recall classified as Class I. Nationwide recall due to stretching or fracture of the sheath during use.
Continue reading...Cordis CROSSOVER Sheath Introducer – Recall
23. December 2009
Comments Off
[UPDATED 12/23/2009] Recall classified as Class I. Nationwide recall due to stretching or fracture of the sheath during use.
Continue reading...Steris System 1 Processor: FDA Notice and Recommendations
17. December 2009
Comments Off
[UPDATED 12/17/2009] List of alternative products added. Unapproved device with potential for improper sterilization and disinfection.
Continue reading...Alka-Seltzer Plus Day & Night Cold Formula Liquid Gels – Incorrect Packaging
9. December 2009
Comments Off
One lot recalled because labeling on the foil blister card of certain packages were printed with the label reversed, and consumers may not be aware of the warnings of an antihistamine that could cause drowsiness.
Continue reading...CT Brain Perfusion Scans Safety Investigation: Initial Notification
7. December 2009
Comments Off
[UPDATED 12/07/2009] FDA identified at least 50 additional patients exposed to excess radiation; interim recommendations for imaging facilities provided.
Continue reading...Voltaren Gel (diclofenac sodium topical gel) 1% – Hepatic Effects Labeling Changes
4. December 2009
Comments Off
Cases of drug-induced hepatotoxicity reported, including liver necrosis, jaundice, fulminant hepatitis with and without jaundice, and liver failure.
Continue reading...
31. December 2009
Comments Off